Lv31
220 积分 2022-03-15 加入
Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing
2小时前
已完结
[Expert consensus on clinical practice of EGFR exon20 insertion detection in non-small cell lung cancer in China (2024 edition)]
9个月前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
9个月前
已完结
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
9个月前
已完结
Alectinib for treating patients with metastatic ALK-positive NSCLC: systematic review and network metanalysis
1年前
已完结
Atezolizumab + obinutuzumab + venetoclax in patients with relapsed or refractory diffuse large B-cell Lymphomas (R/R DLBCL): Primary analysis of a phase II trial from LYSA
1年前
已关闭
Clinical application of circulating tumour DNA in colorectal cancer
1年前
已完结
Lenalidomide plus rituximab for the initial treatment of elderly frail patients with DLBCL: the FIL_ReRi Phase 2 Study
1年前
已完结
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection
2年前
已完结
皖公网安备34019202002308
